The Netherlands Cancer Institute in Amsterdam was founded in 1913 by, among others, the surgeon Jacob Rotgans. The NKI, together with the Antoni van Leeuwenhoekziekenhuis, is formed into the NKI-AVL, which combines a scientific research institute with a specialized clinic focused on combating the disease cancer.

During the past decade, NKI-AVL, Department of Thoracic-Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "NKI-AVL, Department of Thoracic-Oncology" are "ALK-positive Non-small Cell Lung Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "NKI-AVL, Department of Thoracic-Oncology" in a lesser frequency.

Most popular intervention types in "NKI-AVL, Department of Thoracic-Oncology" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Ceritinib" (1 trials), "INC280 (capmatinib)" (1 trials), "INC280 single agent" (1 trials) and "erlotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "NKI-AVL, Department of Thoracic-Oncology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "NKI-AVL, Department of Thoracic-Oncology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in NKI-AVL, Department of Thoracic-Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in NKI-AVL, Department of Thoracic-Oncology, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".